Orange Book product · Generic (ANDA)
FLUCYTOSINE
FLUCYTOSINE
Generic (ANDA)ANDA 213665TE ABRX AUROBINDO PHARMA LTD
At a glance
May 01, 2020
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 01, 2020
6 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
FLUCYTOSINE
Strength
250MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 213665
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of FLUCYTOSINE
- —ANCOBONBrand (NDA)
NDA 017001 · BAUSCH
- 2025FLUCYTOSINEGeneric (ANDA)
ANDA 218005 · LAURUS
- 2020FLUCYTOSINEGeneric (ANDA)
ANDA 212632 · STRIDES PHARMA
- 2018FLUCYTOSINEGeneric (ANDA)
ANDA 207536 · STRIDES PHARMA
- 2017FLUCYTOSINEGeneric (ANDA)
ANDA 206550 · HIKMA
- 2017FLUCYTOSINEGeneric (ANDA)
ANDA 204652 · NOVEL LABS INC
- 2011FLUCYTOSINEGeneric (ANDA)
ANDA 201566 · SIGMAPHARM LABS LLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
